Anti-SL9A7/ SLC9A7/ NHE-7 monoclonal antibody
Anti-SL9A7/ SLC9A7/ NHE-7 antibody for FACS & in-vivo assay
Go to SLC9A7/SLC9A7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP1675-Ab-1/ GM-Tg-hg-MP1675-Ab-2 | Anti-Human SLC9A7 monoclonal antibody | Human |
GM-Tg-rg-MP1675-Ab-1/ GM-Tg-rg-MP1675-Ab-2 | Anti-Rat SLC9A7 monoclonal antibody | Rat |
GM-Tg-mg-MP1675-Ab-1/ GM-Tg-mg-MP1675-Ab-2 | Anti-Mouse SLC9A7 monoclonal antibody | Mouse |
GM-Tg-cynog-MP1675-Ab-1/ GM-Tg-cynog-MP1675-Ab-2 | Anti-Cynomolgus/ Rhesus macaque SLC9A7 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP1675-Ab-1/ GM-Tg-felg-MP1675-Ab-2 | Anti-Feline SLC9A7 monoclonal antibody | Feline |
GM-Tg-cang-MP1675-Ab-1/ GM-Tg-cang-MP1675-Ab-2 | Anti-Canine SLC9A7 monoclonal antibody | Canine |
GM-Tg-bovg-MP1675-Ab-1/ GM-Tg-bovg-MP1675-Ab-2 | Anti-Bovine SLC9A7 monoclonal antibody | Bovine |
GM-Tg-equg-MP1675-Ab-1/ GM-Tg-equg-MP1675-Ab-2 | Anti-Equine SLC9A7 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP1675-Ab-1/ GM-Tg-hg-MP1675-Ab-2; GM-Tg-rg-MP1675-Ab-1/ GM-Tg-rg-MP1675-Ab-2; GM-Tg-mg-MP1675-Ab-1/ GM-Tg-mg-MP1675-Ab-2; GM-Tg-cynog-MP1675-Ab-1/ GM-Tg-cynog-MP1675-Ab-2; GM-Tg-felg-MP1675-Ab-1/ GM-Tg-felg-MP1675-Ab-2; GM-Tg-cang-MP1675-Ab-1/ GM-Tg-cang-MP1675-Ab-2; GM-Tg-bovg-MP1675-Ab-1/ GM-Tg-bovg-MP1675-Ab-2; GM-Tg-equg-MP1675-Ab-1/ GM-Tg-equg-MP1675-Ab-2 |
Products Name | Anti-SLC9A7 monoclonal antibody |
Format | mab |
Target Name | SLC9A7 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-SLC9A7 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species SL9A7/ SLC9A7/ NHE-7 VLP (virus-like particle) (Products Developing) |
Target information
Target ID | GM-MP1675 |
Target Name | SLC9A7 |
Gene ID | 84679,236727,317170,710906,609144,101098119,522505,100060383 |
Gene Symbol and Synonyms | 6330509M05Rik,A530087D17Rik,MRX108,NHE-7,NHE7,SLC9A6,SLC9A7 |
Uniprot Accession | Q96T83 |
Uniprot Entry Name | SL9A7_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000065923 |
Target Classification | N/A |
The target: SLC9A7, gene name: SLC9A7, also named as NHE-7, NHE7, SLC9A6. This gene encodes a sodium and potassium/ proton antiporter that is a member of the solute carrier family 9 protein family. The encoded protein is primarily localized to the trans-Golgi network and is involved in maintaining pH homeostasis in organelles along the secretory and endocytic pathways. This protein may enhance cell growth of certain breast tumors. This gene is part of a gene cluster on chromosome Xp11.23. A pseudogene of this gene is found on chromosome 12. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2012].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.